Literature DB >> 11924725

Influence of plasma aldosterone on left ventricular geometry and diastolic function in treated essential hypertension.

Yoshio Iwashima1, Takeshi Horio, Setsuko Kuroda, Shuichi Takishita, Yuhei Kawano.   

Abstract

Since aldosterone is known to promote interstitial fibrosis in cardiac tissues, it is possible that aldosterone may influence cardiac structure and function. In the present study, we investigated whether plasma aldosterone concentration (PAC) is related to the distinct patterns of left ventricular (LV) geometry and LV diastolic function in treated essential hypertension. In 92 patients with chronically treated essential hypertension, two-dimensional and Doppler echocardiographic examinations were performed and LV inflow velocities were measured for evaluation of LV diastolic function. When patients were divided into four groups by the different LV geometric patterns, PAC in patients with eccentric hypertrophy was significantly higher than in those with concentric hypertrophy (15.2+/-2.1 vs. 10.0+/-0.7 ng/dl, p<0.01). However, the ratio of the peak velocity of early diastolic filling to that of atrial filling (EIA), an index of LV diastolic function, was significantly decreased in patients with concentric hypertrophy compared with those showing normal geometry. In the relationship between PAC and LV diastolic function, PAC was negatively correlated with EIA (r=-0.35, p<0.05) only in the subgroup with normal relative wall thickness (i.e., without the concentric change in LV geometry). A multiple linear regression analysis showed that PAC was one of the independent determinants of E/A in the overall subject group. These observations indicate that PAC is associated with the eccentric change in LV geometry in patients with treated essential hypertension and also suggest that the increase in PAC participates in the impairment of LV diastolic function apart from the concentric change in LV geometry, although concentric hypertrophy clearly impairs LV diastolic function.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11924725     DOI: 10.1291/hypres.25.49

Source DB:  PubMed          Journal:  Hypertens Res        ISSN: 0916-9636            Impact factor:   3.872


  10 in total

1.  Association among serum uric acid, cardiovascular risk, and arterial stiffness: a cross-sectional study in She ethnic minority group of Fujian Province in China.

Authors:  Y Lin; X Lai; G Chen; Y Xu; B Huang; Y Wu; Z Chen; L Yao; F Lin; Y Qiao; Z Chen; S Zhu; H Huang; J Wen
Journal:  J Endocrinol Invest       Date:  2011-05-30       Impact factor: 4.256

2.  Plasma aldosterone and its relationship with left ventricular mass in hypertensive patients with early-stage chronic kidney disease.

Authors:  Giuseppe Mulè; Emilio Nardi; Laura Guarino; Valentina Cacciatore; Giulio Geraci; Ilenia Calcaterra; Bruno Oddo; Francesco Vaccaro; Santina Cottone
Journal:  Hypertens Res       Date:  2015-01-08       Impact factor: 3.872

3.  Determinants of left ventricular hypertrophy in hypertensive patients: identification of high-risk patients by metabolic, vascular, and inflammatory risk factors.

Authors:  Maya Peer; Mona Boaz; Matas Zipora; Marina Shargorodsky
Journal:  Int J Angiol       Date:  2013-12

4.  Polymorphism modulates symptomatic response to antiarrhythmic drug therapy in patients with lone atrial fibrillation.

Authors:  Dawood Darbar; Alison A Motsinger; Marylyn D Ritchie; James V Gainer; Dan M Roden
Journal:  Heart Rhythm       Date:  2007-02-09       Impact factor: 6.343

5.  Timp-3 deficiency impairs cognitive function in mice.

Authors:  Yoshichika Baba; Osamu Yasuda; Yukihiro Takemura; Yasuyuki Ishikawa; Mitsuru Ohishi; Jun Iwanami; Masaki Mogi; Nobutaka Doe; Masatsugu Horiuchi; Nobuyo Maeda; Keisuke Fukuo; Hiromi Rakugi
Journal:  Lab Invest       Date:  2009-10-05       Impact factor: 5.662

6.  Relations of biomarkers representing distinct biological pathways to left ventricular geometry.

Authors:  Raghava S Velagaleti; Philimon Gona; Daniel Levy; Jayashri Aragam; Martin G Larson; Geoffrey H Tofler; Wolfgang Lieb; Thomas J Wang; Emelia J Benjamin; Ramachandran S Vasan
Journal:  Circulation       Date:  2008-11-10       Impact factor: 29.690

7.  Ambulatory blood pressure profile and left ventricular geometry in Nigerian hypertensives.

Authors:  O E Ajayi; E A Ajayi; O A Akintomide; R A Adebayo; S A Ogunyemi; A T Oyedeji; M O Balogun
Journal:  J Cardiovasc Dis Res       Date:  2011-07

8.  Blood pressure response to an exercise treadmill test, and echocardiographic left ventricular geometry in Nigerian normotensive diabetics.

Authors:  E A Ajayi; M O Balogun; O A Akintomide; R A Adebayo; O E Ajayi; R T Ikem; S A Ogunyemi; A T Oyedeji
Journal:  Cardiovasc J Afr       Date:  2010 Mar-Apr       Impact factor: 1.167

9.  Cardiac magnetic resonance imaging of myocardial mass and fibrosis in primary aldosteronism.

Authors:  Marianne Aa Grytaas; Kjersti Sellevåg; Hrafnkell B Thordarson; Eystein S Husebye; Kristian Løvås; Terje H Larsen
Journal:  Endocr Connect       Date:  2018-02-12       Impact factor: 3.335

10.  Angiotensin-converting enzyme gene 2350 G/A polymorphism and susceptibility to atrial fibrillation in Han Chinese patients with essential hypertension.

Authors:  Min-Hui Jiang; Ya-Min Su; Jian-Zhong Tang; Yan-Bo Shen; Xin-Tao Deng; Ding-Shan Yuan; Jie Wu; Min Pan; Zhong-Wei Huang
Journal:  Clinics (Sao Paulo)       Date:  2013-11       Impact factor: 2.365

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.